Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03433053 · ClinicalTrials.gov registry record · NA

Developing and Examining Evidenced-Based HIV Testing Messages

A NA study of HIV/AIDS, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
141
Enrollment target
1
Study location

NCT03433053 is a NA study of HIV/AIDS that has completed, run by Virginia Commonwealth University. The registered enrollment target is 141 participants, below the 33,178-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03433053, a NA study of HIV/AIDS, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
141 participants
Enrollment target
1
Study location

Study Summary

The goals of this study are to: 1. Develop a HIV test message tailored for African American women. A generic non-tailored message will be developed as well for comparison. A third group will be included that will not be exposed to any message at all. 2. Test the effectiveness of both messages on reported future intentions to get tested for HIV and HIV test behavior at 3 month follow up.

Conditions Studied

HIV/AIDS

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL HIV Testing Message Intervention

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 141 participants
Start Date 2018-10-24
Est. Completion 2019-06-24
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03433053

The ClinicalTrials.gov registry entry for NCT03433053 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,178-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT03433053 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03433053 about?

NCT03433053 is a clinical study titled "Developing and Examining Evidenced-Based HIV Testing Messages". The goals of this study are to: 1. Develop a HIV test message tailored for African American women. A generic non-tailored message will be developed as well for comparison. A third group will be included that will not be exposed to any message at all. 2. Test the effectiveness of both messages on re...

What is the current status of trial NCT03433053?

This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2018-10-24. Estimated completion is 2019-06-24.

What conditions does trial NCT03433053 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT03433053?

The interventions under investigation include: Control (BEHAVIORAL), HIV Testing Message Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03433053?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03433053 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV/AIDS

All registered trials for this condition

Virginia

All trials with a study site in Virginia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.